Effectiveness of educational materials on levels of knowledge of thyroid associated orbitopathy in an endocrinology clinic.
Graves' orbitopathy
Patient knowledge
Thyroid eye disease
Thyroid-associated orbitopathy
Journal
PEC innovation
ISSN: 2772-6282
Titre abrégé: PEC Innov
Pays: Netherlands
ID NLM: 9918367980406676
Informations de publication
Date de publication:
15 Dec 2023
15 Dec 2023
Historique:
received:
29
06
2023
revised:
26
09
2023
accepted:
30
09
2023
medline:
16
10
2023
pubmed:
16
10
2023
entrez:
16
10
2023
Statut:
epublish
Résumé
We aim to assess and quantify basic knowledge about TAO in patients presenting to an endocrinology clinic and the effect of different educational materials on patients' knowledge. This study was conducted in a tertiary care center involving 255 patients presenting to an endocrinology clinic. The study was divided into three consecutive phases: 1. a control phase without any educational materials in the waiting room, 2. exposure to educational posters, and 3. exposure to educational pamphlets. In the control population, only 16.5% of patients reported having knowledge of TAO, with a low average TAO-K score of 29.8 (out of 100). After the poster and pamphlet interventions, the percentage of patients having any knowledge of TAO increased across the control, poster and pamphlet phases: 16.5%, 25.9%, 63.5% respectively ( This study confirms that patients with thyroid dysfunction have a low level of awareness and depth of knowledge of TAO. We suggest the dissemination of educational material to increase the knowledge of TAO in thyroid patients. This will help with early symptom detection and ensure proper management of this interdisciplinary condition.
Identifiants
pubmed: 37842176
doi: 10.1016/j.pecinn.2023.100225
pii: S2772-6282(23)00105-X
pmc: PMC10570698
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100225Informations de copyright
© 2023 The Authors. Published by Elsevier B.V.
Déclaration de conflit d'intérêts
The authors have no financial disclosures or conflicts of interest to declare. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Références
N Engl J Med. 2011 May 19;364(20):1920-31
pubmed: 21591944
Clin Endocrinol (Oxf). 2001 Sep;55(3):283-303
pubmed: 11589671
Clin Endocrinol (Oxf). 2017 Dec;87(6):853-859
pubmed: 28755510
Aust J Prim Health. 2016;22(3):198-210
pubmed: 27117952
Orbit. 2008;27(6):419-25
pubmed: 19085296
Br J Ophthalmol. 2015 Nov;99(11):1531-5
pubmed: 25953846
Autoimmun Rev. 2018 Jul;17(7):639-643
pubmed: 29729448
Best Pract Res Clin Endocrinol Metab. 2012 Jun;26(3):325-37
pubmed: 22632369
Thyroid. 2019 Apr;29(4):557-562
pubmed: 30688164
N Engl J Med. 2010 Feb 25;362(8):726-38
pubmed: 20181974
J Cancer Educ. 1996 Fall;11(3):148-52
pubmed: 8877574
Ann Fam Med. 2008 Jan-Feb;6 Suppl 1:S33-6
pubmed: 18195306
Orbit. 2017 Jun;36(3):159-169
pubmed: 28296512
Br J Gen Pract. 1994 Dec;44(389):583-5
pubmed: 7748670
Thyroid. 2014 Jan;24(1):67-72
pubmed: 24040878
Eur J Gastroenterol Hepatol. 2016 May;28(5):582-7
pubmed: 27015016
Cureus. 2022 Jul 27;14(7):e27336
pubmed: 36043002
BMJ Open. 2015 Jun 03;5(6):e007612
pubmed: 26041493
Patient Prefer Adherence. 2013 Jun 04;7:489-97
pubmed: 23766635
Intern Med. 2014;53(5):353-60
pubmed: 24583420
Br J Gen Pract. 2018 Dec;68(677):e869-e876
pubmed: 30348885
J Clin Endocrinol Metab. 2013 Jan;98(1):145-52
pubmed: 23185037